Enveric Biosciences's total assets for Q3 2025 were $4.36M, an increase of 22.93% from the previous quarter. ENVB total liabilities were $905.88K for the fiscal quarter, a -33.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.